September 13, 2018
Biophytis obtains a €10 million loan with Kreos Capital. Read the Press Release
September 04, 2018
Biophytis Provides Enrollment Update in Its Phase 2b SARA-OBS and SARA-INT Studies of Sarconeos in Sarcopenia. Read the Press Release
August 30, 2018
BIOPHYTIS to Present at the H.C. Wainwright 20th Annual Global Investment Conference. Read the Press Release
July 26, 2018
BIOPHYTIS: 2017 Annual Report filed. Read the Press Release
July 02, 2018
Biophytis appoints a new Chief Medical Officer based in the USA. Read the Press Release
June 04, 2018
Results of the Extraordinary General Meeting held on June 4, 2018. Passing of all the resolutions. Read the Press Release
May 28, 2018
Biophytis receives favourable opinion from EMA for the Orphan Drug designation of Sarconeos in Duchenne Muscular Dystrophy (DMD). Read the Press Release
May 24, 2018
Inclusion of the first patient in Phase 2b Study in Sarcopenia. Read the Press Release
May 16, 2018
Results of the 2018 Annual Meeting of Shareholders. Read the Press Release
May 15, 2018
Biophytis receives Orphan Drug Designation from the FDA for Sarconeos in Duchenne Muscular Dystrophy (DMD). Read the Press Release